Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
Prescriber Fidelity to a Medication Management Evidence-Based Practice in the Treatment of Schizophrenia
Psychiatric Services, 07/02/09
Howard PB et al. - Implementation and monitoring of MedMAP were feasible in these community mental health settings. Additional implementation projects are crucial for advancing evidence-based practice in clinical settings.
Methods- This three-year longitudinal intervention study implemented MedMAP in six community mental health centers in Kentucky.
- Nine psychiatrists and five advanced practice psychiatric nurses with prescriptive authority participated in the study.
- Prescribers were trained in the use of MedMAP about one month before implementation, and MedMAP principles were reinforced throughout the study.
- Four posttraining assessments were conducted at each site at approximately four-month intervals over a period of 30 months.
- An 18-item scale was used to assess baseline and posttraining prescriber fidelity over a period of 30 months in 900 randomly selected medical records.
- Average fidelity scores improved significantly over baseline at each of the four postimplementation fidelity assessments.
- Training effects were most evident at the second posttraining fidelity assessment, but effects persisted over the course of the study.
- There was considerable variability in scores across items both at baseline and subsequently.
- Posttraining improvement was greatest in patient education, documentation of illness and medication history, and simplification of medication regimen.
Today in Child/Adolescent Psych...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
A Double-Blind, Randomized, Placebo-Controlled Study of Fixed-Dose Aripiprazole in Children and Adolescents With Autistic Disorder
Journal of the American Academy of Child and Adolescent Psychiatry, 10/06/09
How adolescents who cut themselves differ from those who take overdoses
European Child and Adolescent Psychiatry, 10/05/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Does Dual Antidepressant Therapy as Initial Treatment Hasten and Increase Remission from Depression
Journal of Psychiatric Practice, 09/29/09
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Management of agitation and aggression associated with Alzheimers disease: controversies and possible solutions
Current Opinion in Psychiatry, 10/12/09
Today in Schizophrenia/Psychosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Journal of Psychopharmacology, 10/19/09
Acupuncture for schizophrenia: a systematic review and meta-analysis
International Journal of Clinical Practice, 10/16/09
Sponsor
Article Search
Sponsor


See Latest Articles


